4592 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
SanBio Co., Ltd. engages in the development, production and sale of regenerative cells medicines. It provides regenerative therapies for neurological disorders that include stroke, traumatic brain injury, eye diseases, and Parkinson's disease. The company was founded on February 27, 2013 and is headquartered in Tokyo, Japan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
4592 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company